These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 15162419)

  • 1. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H; Andersson U
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytokine activity of HMGB1.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
    Sun NK; Chao CC
    Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein induces high-mobility group box-1 protein release through activation of p38MAPK in macrophage RAW264.7 cells.
    Kawahara K; Biswas KK; Unoshima M; Ito T; Kikuchi K; Morimoto Y; Iwata M; Tancharoen S; Oyama Y; Takenouchi K; Nawa Y; Arimura N; Jie MX; Shrestha B; Miura N; Shimizu T; Mera K; Arimura S; Taniguchi N; Iwasaka H; Takao S; Hashiguchi T; Maruyama I
    Cardiovasc Pathol; 2008; 17(3):129-38. PubMed ID: 18402807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
    Andersson U; Tracey KJ
    Rheum Dis Clin North Am; 2004 Aug; 30(3):627-37, xi. PubMed ID: 15261345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 release in co-cultures of porcine endothelial and human T cells.
    Kawahara K; Setoyama K; Kikuchi K; Biswas KK; Kamimura R; Iwata M; Ito T; Morimoto Y; Hashiguchi T; Takao S; Maruyama I
    Xenotransplantation; 2007 Nov; 14(6):636-41. PubMed ID: 17991152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
    Czura CJ; Yang H; Tracey KJ
    J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial infection induces the secretion of high-mobility group box 1 protein.
    Grover A; Taylor J; Troudt J; Keyser A; Sommersted K; Schenkel A; Izzo AA
    Cell Microbiol; 2008 Jun; 10(6):1390-404. PubMed ID: 18331466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 as a cytokine and therapeutic target.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1, a potent proinflammatory cytokine in sepsis.
    Huang W; Tang Y; Li L
    Cytokine; 2010 Aug; 51(2):119-26. PubMed ID: 20347329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1: a signal of necrosis.
    Raucci A; Palumbo R; Bianchi ME
    Autoimmunity; 2007 Jun; 40(4):285-9. PubMed ID: 17516211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
    Voll RE; Urbonaviciute V; Herrmann M; Kalden JR
    Isr Med Assoc J; 2008 Jan; 10(1):26-8. PubMed ID: 18300566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.